6 months ago
TMO
AnalystsDaniel AriasDaniel Arias's Stock Forecasts
AnalystsDaniel Arias
Analyst Ranking
Top 13%
#691 out of 5326 analysts
Average Return
+13.55%
Win Rate
55%49 out of 89
Risk vs Reward
Poor
Good
Daniel Arias's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Nanostring Technologies IncNSTGQ | +198.16% | $22.86 | $68.16 | 2020-04-02 - 2021-04-01 | Strong Buy |
Guardant Health IncGH | +159.01% | $60.18 | $155.87 | 2025-09-25 - 2026-07-17 | Strong Buy |
908 Devices IncMASS | +152.14% | $2.34 | $5.90 | 2024-11-13 - 2025-11-12 | Strong Buy |
10x Genomics IncTXG | +141.39% | $18.12 | $43.74 | 2026-02-13 - 2026-07-17 | Strong Buy |
Guardant Health IncGH | +140.49% | $42.87 | $103.10 | 2025-02-21 - 2026-02-20 | Strong Buy |
Daniel Arias Analyst Color
Get additional color on Daniel Arias's coverage of popular stocks
6 months ago
GH
9 months ago
EXAS
10 months ago
GH
a year ago
GH
2 years ago
TMO
2 years ago
AVTR
2 years ago
TMO
2 years ago
RGEN
3 years ago
TXG
Daniel Arias's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Aib Data Centers IncAIB | 1 | Strong Buy | $6.75 | +281.36% | Initiates Coverage On | 19 days ago |
Qiagen NvQGEN | 5 | Hold | $36.00 | -12.52% | Maintains | 2 months ago |
Mettler Toledo International IncMTD | 8 | Strong Buy | $1,400.00 | +6.87% | Maintains | 2 months ago |
Alamar Biosciences IncALMR | 1 | Strong Buy | $28.00 | +7.90% | Initiates Coverage On | 2 months ago |
Revvity IncRVTY | 5 | Hold | $100.00 | -9.21% | Maintains | 2 months ago |
Thermo Fisher Scientific IncTMO | 14 | Strong Buy | $600.00 | +12.68% | Maintains | 3 months ago |
10x Genomics IncTXG | 8 | Strong Buy | $25.00 | -42.84% | Maintains | 5 months ago |
Guardant Health IncGH | 6 | Strong Buy | $130.00 | -16.60% | Maintains | 5 months ago |
Bio Techne CorpTECH | 12 | Hold | $65.00 | -9.87% | Maintains | 6 months ago |
Illumina IncILMN | 12 | Strong Buy | $155.00 | -16.96% | Maintains | 6 months ago |
Billiontoone IncBLLN | 1 | Strong Buy | $145.00 | +11.27% | Initiates Coverage On | 8 months ago |
Exact Sciences CorpEXAS | 7 | Hold | $105.00 | -94.37% | Downgrades | 8 months ago |
Bruker CorpBRKR | 7 | Hold | $40.00 | -31.31% | Maintains | a year ago |
Avantor IncAVTR | 7 | Hold | $12.00 | +8.40% | Maintains | a year ago |
Danaher CorpDHR | 6 | Strong Buy | $260.00 | N/A | Upgrades | a year ago |
Maxcyte IncMXCT | 2 | Strong Buy | $9.00 | N/A | Maintains | a year ago |
908 Devices IncMASS | 2 | Strong Buy | $6.00 | N/A | Maintains | 2 years ago |
Tempus Ai IncTEM | 2 | Hold | $65.00 | N/A | Downgrades | 2 years ago |
Waters CorpWAT | 11 | Hold | $360.00 | N/A | Maintains | 2 years ago |
Agilent Technologies IncA | 13 | Strong Buy | $151.00 | N/A | Maintains | 2 years ago |
Maravai Lifesciences Holdings IncMRVI | 2 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Repligen CorpRGEN | 6 | Strong Buy | $207.00 | N/A | Maintains | 2 years ago |
Codexis IncCDXS | 2 | Strong Buy | $5.00 | N/A | Maintains | 3 years ago |
Phenomex IncCELL | 3 | Hold | $3.00 | N/A | Maintains | 3 years ago |
Somalogic IncSLGC | 2 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Renalytix PLCRNLXY | 2 | Strong Buy | $7.00 | N/A | Maintains | 4 years ago |
Absci CorpABSI | 2 | Hold | $10.00 | N/A | Maintains | 4 years ago |
Nanostring Technologies IncNSTGQ | 1 | Strong Buy | $35.00 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.